These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35565229)

  • 21. The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC.
    Song Q; Zhang X
    Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diet and gut microbiome in fatty liver and its associated liver cancer.
    Pan Y; Zhang X
    J Gastroenterol Hepatol; 2022 Jan; 37(1):7-14. PubMed ID: 34664301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment.
    Bartolini I; Risaliti M; Tucci R; Muiesan P; Ringressi MN; Taddei A; Amedei A
    World J Gastrointest Oncol; 2021 Nov; 13(11):1616-1631. PubMed ID: 34853639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment.
    Spanu D; Pretta A; Lai E; Persano M; Donisi C; Mariani S; Dubois M; Migliari M; Saba G; Ziranu P; Pusceddu V; Puzzoni M; Astara G; Scartozzi M
    World J Hepatol; 2022 Jul; 14(7):1319-1332. PubMed ID: 36158925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
    Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
    Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Gut Microbiota in Hepatocarcinogenesis.
    Gupta H; Youn GS; Shin MJ; Suk KT
    Microorganisms; 2019 May; 7(5):. PubMed ID: 31060311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research progress of gut microbiota in hepatocellular carcinoma.
    Li K; Liu J; Qin X
    J Clin Lab Anal; 2022 Jul; 36(7):e24512. PubMed ID: 35719048
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Ma H; Yang L; Liang Y; Liu F; Hu J; Zhang R; Li Y; Yuan L; Feng F
    Gut Microbes; 2024; 16(1):2297846. PubMed ID: 38270111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy.
    Luo W; Guo S; Zhou Y; Zhao J; Wang M; Sang L; Chang B; Wang B
    Front Microbiol; 2022; 13():873160. PubMed ID: 35572649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response.
    Delaune V; Orci LA; Lacotte S; Peloso A; Schrenzel J; Lazarevic V; Toso C
    Expert Opin Biol Ther; 2018 Oct; 18(10):1061-1071. PubMed ID: 30173562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review.
    Muscolino P; Granata B; Omero F; De Pasquale C; Campana S; Calabrò A; D'Anna F; Drommi F; Pezzino G; Cavaliere R; Ferlazzo G; Silvestris N; Speranza D
    Front Oncol; 2023; 13():1247614. PubMed ID: 37692859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development through Targeting the Gut-Liver Axis.
    Qu L; Ma X; Fan D
    J Agric Food Chem; 2021 Sep; 69(35):10121-10137. PubMed ID: 34415764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota, fatty liver disease, and hepatocellular carcinoma.
    Chu H; Williams B; Schnabl B
    Liver Res; 2018 Mar; 2(1):43-51. PubMed ID: 30416839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma.
    Yu Q; Wu L; Ji J; Feng J; Dai W; Li J; Wu J; Guo C
    J Hepatocell Carcinoma; 2020; 7():271-288. PubMed ID: 33150145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Microbiome and Hepatocellular Carcinoma.
    Rattan P; Minacapelli CD; Rustgi V
    Liver Transpl; 2020 Oct; 26(10):1316-1327. PubMed ID: 32564483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.
    Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; Camisaschi C; Picca A; Tuccitto A; Gasbarrini A; Pompili M; Mazzaferro V
    Hepatology; 2019 Jan; 69(1):107-120. PubMed ID: 29665135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The deficiency of FKBP-5 inhibited hepatocellular progression by increasing the infiltration of distinct immune cells and inhibiting obesity-associated gut microbial metabolite.
    Zhang C; Cui X; Feng L; Han Z; Peng D; Fu W; Xing Y
    J Gastrointest Oncol; 2021 Apr; 12(2):711-721. PubMed ID: 34012660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
    Deng T; Li J; He B; Chen B; Liu F; Chen Z; Zheng J; Shi Z; Zhang T; Deng L; Yu H; Yang J; Wu L; Shan Y; Yu Z; Chen X; Wang Y; Chen G
    Hepatol Int; 2022 Feb; 16(1):99-111. PubMed ID: 35064546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma.
    Ponziani FR; Nicoletti A; Gasbarrini A; Pompili M
    Ther Adv Med Oncol; 2019; 11():1758835919848184. PubMed ID: 31205505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows.
    Costante F; Airola C; Santopaolo F; Gasbarrini A; Pompili M; Ponziani FR
    World J Gastrointest Oncol; 2022 Sep; 14(9):1622-1636. PubMed ID: 36187401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.